Odborné akce s tématikou sekce pořádané v zahraničí

image_pdfimage_print

2023

ASCO GU 2023

The American Society of Clinical Oncology’s annual Genitourinary Cancers Symposium

Termín konání: 16. – 18. 2. 2023

Místo konání: San Francisco, USA

Více informací na stránkách ASCO: Attend | ASCO Genitourinary Cancers Symposium

2022

ASCO 2022

Termín konání: 3. – 7. 6. 2022

Místo konání: Chicago, USA

Více informací na stránkách akce: Attend | ASCO Annual Meeting

 

ESMO Congress 2022 

Termín konání: 9. – 13. září 2022

Místo konání: Paříž

Více informací na stránkách akce: ESMO Congress 2022

 

EMUC 2022

Termín konání: 10. – 13. listopadu 2022

Místo konání: Budapešť

Více informací na stránkách akce: 14th European Multidisciplinary Congress on Urological Cancers – EMUC22

 

2019

Webinář: Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care – Prostate Cancer

Termín konání: 24. června 2019

The Emerging Role of Tumor and Germline Genetic Testing and the Treatment of Advanced Disease
Many clinicians are uninformed on the emerging role of germline and tumor genetic testing for risk stratification of men with localized prostate cancer. However, this information is essential to assure selection of the best management option, which may allow many younger men with indolent cancer to avoid treatment and its side effects. In addition, clinicians should be made aware of recent clinical trial results in the non-metastatic CRPC setting, so patients can delay the onset of metastases as long as possible. Finally, most clinicians have little experience using immunotherapy in men with progressive, metastatic castration-resistant prostate cancer, so they require education on patient selection and adverse effect management.

Více informací o webináři: https://education.nccn.org/node/85913#group-tabs-node-course-default1 

 

2018

2018 Genitourinary Cancers Symposium

Termín konání: 8. – 10. 2. 2018

Místo konání: Moscone West Building, San Francisco

The 2018 Genitourinary Cancers Symposium will feature an array of multidisciplinary sessions covering prostate, renal, urothelial, testicular, and adrenal cancers. World-renowned faculty will present on the most clinically relevant topics across these disease sites and offer insight into the future of cancer care for GU malignancies.

This year, the program will include case-based discussions and debates in each disease site to highlight the clinical application of the latest research in the field. Topics for these presentations include “Magnetic Resonance and Magnetic Resonance-Directed Biopsy in Localized Prostate Cancer: Where is the Field Moving?,” “Multimodality Approach to Locally Advanced Bladder Cancer,” “Management of Residual Masses in Germ Cell Tumors,” and “Comprehensive Characterization and Management of the Incidental Renal Mass.” Subspecialties represented on these and other panels in the program include medical oncology, radiation oncology, surgery, urology, and pathology.

View the Full Symposium Program

See Featured Sessions

Learn More About Poster Sessions

Více informací na webových stránkách akce: https://gucasym.org/

 

EAU Update on Bladder Cancer (BCa18)

Termín konání: 8. – 9. 6. 2018

Místo konání: Munich, Germany

With novel systemic therapies, new agents and developments in pathology and genomics, treatment strategies for urothelial tumours have become more complex. The new EAU Update on Bladder Cancer (BCa18) on 8 and 9 June in Munich, Germany, offers the opportunity to resolve your decision-making dilemmas.

This fully interactive two-day event provides:

  • In-depth, comprehensive and practical updates on bladder cancer management
  • Latest developments emerging from ongoing clinical immunotherapy studies
  • Direct feedback and interaction with experts from ESMO and EAU
  • Point-by-point assessment of diagnostic and treatment strategies
  • Evaluation of participant’s knowledge.

Whether you need a full overview of guideline-compliant therapies or fresh insights on multidisciplinary approaches, BCa18 is a compact, expert-directed meeting.

Více informací: https://bca.uroweb.org/

 

NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ 

Termín konání: 22.-24. 8. 2018

Místo konání: Rosen Shingle Creek, Orlando, Florida

The NCCN Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ attracts more than 1,600 registrants from across the United States and the globe including oncologists (in both community and academic settings), oncology fellows, nurses, pharmacists, and other health care professionals involved in the care of patients with cancer. Respected opinion leaders present the latest cancer therapies and provide updates on selected NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), the data upon which the NCCN Guidelines® are based, and quality initiatives in oncology. Topics change annually but focus on the major cancers and supportive care areas.

Více informací na webových stránkách akce: https://www.nccn.org/professionals/meetings/annual_conference.aspx

2017

UROwebinar: Treatment strategy in muscle invasive bladder cancer

Treatment strategy in muscle invasive bladder cancer

Presenter: Prof. Muhammad Shamim Khan (GB)
Save the date: Tuesday, 19 December
Time: 18:30 to 19:30 (Central European Time)

The learning objectives of this webinar are:

  • Aetiology, modes of presentation, clinical, radiological and histopathological assessment
  • The value, disadvantages and contra-indications of neo-adjuvant chemotherapy
  • How to choose the appropriate treatment based on the patient’s age, co-morbidities and pathological factors once appropriately staged
  • Various surgical approaches in radical cystectomy, the preferences of urinary diversions and how to make a rational choice
  • Key aspects of enhanced recovery and oncological outcomes as per disease stage and histopathological variants

 

How to join

Please register online to join the webinar. You will receive your confirmation together with the webinar’s information via email. The webinar is viewable via PC, smartphone or tablet.

9th European Multidisciplinary Meeting on Urological Cancers – EMUC 17

Termín konání: 16.-19. 11. 2017

Místo konání:  Palau de Congressos de Catalunya, Barcelona, Spain

Barcelona, Spain, will host from 16 to 19 November 2017, the 9th European Multidisciplinary Meeting on Urological Cancers (EMUC17), one of Europe’s well-attended international conferences for multidisciplinary specialists with expertise in urological malignancies.

Více informací na webových stránkách akce: http://emuc17.org/

2nd International Prostate Cancer Symposium and Inaugural World Congress of Urologic Oncology

Termín konání: 7. – 9. 9. 2017

Místo konání:  Stern Auditorium, 1468 Madison Avenue, New York

Oncology and Urology Symposium hosted by the Mount Sinai Department of Urology. Directed by senior faculty at the Icahn School of Medicine at Mount Sinai and taught by internationally renowned faculty, attendees will experience live 3D robotic surgeries and be on the front lines of point-counterpoint debates on today’s most important issues in the field.

Více informací na webových stránkách akce: http://mountsinaiurologycme.org/

 

Bench to Bedside – Kidney and Urothelial Cancers

Termín konání: 26.-27. 5. 2017

Místo konání: Medical University of Vienna / General Hospital Vienna (AKH)

B2B Kidney and Urothelial Cancers Congress is an intensive, interactive, one and half-day educational program that brings together renowned international experts in the fields of kidney, bladder and upper tract urothelial cancer.

Více informací na webových stránkách akce: http://controversies-urologic-oncology.com/

Pozvánka s programem: B2B May 2017 Program_Lw_corr pr_17.03.2017 (PDF)

 

2013

13. – 17. 3. 2013
National Comprehensive Cancer Network 18th Annual Conference: Advancing the Standard of Cancer Care™
The Westin Diplomat, Hollywood, Florida, USA

Stránky konference: http://www.nccn.org/professionals/meetings/annual_conference.asp

16. – 17. 5. 2013

Frontiers in Prostate Cancer Translational Research

Megaron Athens International Conference Centre, Athens, Greece

Conference is organized by Professor Christopher Logothetis and The University of Texas MD Anderson Cancer Center.

The “Frontiers in Prostate Cancer Translational Research” Conference will take place in Athens, at the Megaron Athens International Conference Center, on May 16th & 17th, 2013 with internationally recognized speakers.

Further information about the scientific program and the registration procedure is available at the official website of the Congress: http://www.prostatecancer2013.com.

 

Publikováno: 18. 12. 2017

Jarní edukační urologické sympózium 2023

Česká urologie

3/2022
stáhnout

4/2022
stáhnout

Starší čísla časopisu dostupná zde.

Sponzoři

Platinový partner

Stříbrný partner

Stříbrný partner

Stříbrný partner

Stříbrný partner

Stříbrný partner

Bronzoví partneři

Oficiální partneři